Vasowatch assesses risk for postpartum hemorrhage (PPH) accurately and consistently, enabling improved obstetric outcomes for all mothers. Their non-invasive wearable device continuously monitors optical data during labor and delivery to objectively assess the mother's current PPH risk, communicating a change to the clinical care team. The device enables the team to prepare for and provide prompt, appropriate PPH treatment, saving lives and minimizing costly complications.